Orchestra BioMed Holdings (OBIO) Treasury Shares (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has reported Treasury Shares for 7 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares rose 93.08% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 93.08% YoY), while the FY2025 annual figure was $2.3 million, up 9.84% from the prior year.
• Treasury Shares rose to $3.7 million in Q1 2026 per OBIO's latest filing, from $2.3 million in the prior quarter.
• Across five years, Treasury Shares topped out at $16.0 million in Q1 2022 and bottomed at $49237.0 in Q2 2023.
• Historically, Treasury Shares has averaged $4.0 million across 5 years, with a median of $2.3 million in 2025.
• Annual changes were most pronounced in 2023 — Treasury Shares plunged 99.69% — and 2024, when it surged 4928.3%.
• Orchestra BioMed Holdings' Treasury Shares stood at $158589.0 in 2022, then surged by 972.72% to $1.7 million in 2023, then advanced by 23.12% to $2.1 million in 2024, then rose by 9.84% to $2.3 million in 2025, then surged by 61.68% to $3.7 million in 2026.
• Business Quant data shows OBIO's Treasury Shares at $3.7 million in Q1 2026, $2.3 million in Q4 2025, and $2.6 million in Q3 2025.